0001950047-24-007308.txt : 20240920 0001950047-24-007308.hdr.sgml : 20240920 20240920173751 ACCESSION NUMBER: 0001950047-24-007308 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240920 DATE AS OF CHANGE: 20240920 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Edgewise Therapeutics, Inc. CENTRAL INDEX KEY: 0001710072 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 821725586 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-40236 FILM NUMBER: 241314259 BUSINESS ADDRESS: STREET 1: 1715 38TH ST CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 720-262-7002 MAIL ADDRESS: STREET 1: 1715 38TH ST CITY: BOULDER STATE: CO ZIP: 80301 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Donovan Joanne M. CENTRAL INDEX KEY: 0001644087 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O CATABASIS PHARMACEUTICALS, INC. STREET 2: ONE KENDALL SQ. BLDG. 1400E SUITE B14202 CITY: CAMBRIDGE STATE: MA ZIP: 02139 144 1 primary_doc.xml 144 0001644087 XXXXXXXX LIVE 0001710072 EDGEWISE THERAPEUTICS, INC. 001-40236 1715 38th Street Boulder CO 80301 (720) 262-7002 JOANNE DONOVAN Officer Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

7162 202602.95 93772288 09/20/2024 NASDAQ common 05/01/2023 Restricted stock vesting under a registered plan Edgewise Therapeutics Inc. N 7162 05/01/2023 Not Applicable Y 09/20/2024 JOANNE DONOVAN